-
1
-
-
84887102623
-
Glioblastoma and other malignant gliomas: A clinical review
-
1:CAS:528:DC%2BC3sXhsl2gu7nM 24193082 10.1001/jama.2013.280319
-
Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA, 2013, 310(17):1842-1850
-
(2013)
JAMA
, vol.310
, Issue.17
, pp. 1842-1850
-
-
Omuro, A.1
Deangelis, L.M.2
-
2
-
-
48249125791
-
Malignant gliomas in adults
-
1:CAS:528:DC%2BD1cXpt1Sgsrw%3D 18669428 10.1056/NEJMra0708126
-
Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med, 2008,359(5):492-507
-
(2008)
N Engl J Med
, vol.359
, Issue.5
, pp. 492-507
-
-
Wen, P.Y.1
Kesari, S.2
-
3
-
-
84893111710
-
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas - A Pediatric Brain Tumor Consortium study
-
1:CAS:528:DC%2BC2cXpslOmsQ%3D%3D 24311632 10.1093/neuonc/not154
-
Gururangan S, Fangusaro J, Poussaint TY, et al. Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas - a Pediatric Brain Tumor Consortium study. Neuro Oncol, 2014,16(2):310-317
-
(2014)
Neuro Oncol
, vol.16
, Issue.2
, pp. 310-317
-
-
Gururangan, S.1
Fangusaro, J.2
Poussaint, T.Y.3
-
4
-
-
84858288465
-
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy
-
1:CAS:528:DC%2BC38XjtFaqsbs%3D 22156796 10.1097/CAD.0b013e32834ee315
-
Nygaard R, Kivivuori SM. Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. Anticancer Drugs, 2012,23(3):342-346
-
(2012)
Anticancer Drugs
, vol.23
, Issue.3
, pp. 342-346
-
-
Nygaard, R.1
Kivivuori, S.M.2
-
5
-
-
84865596273
-
MicroRNA-34a inhibits human brain glioma cell growth by down-regulation of notch1
-
1:CAS:528:DC%2BC38XosFCrtb0%3D 10.1007/s11596-012-0064-0
-
Yu X, Zhang WD, Ning Q, et al. MicroRNA-34a inhibits human brain glioma cell growth by down-regulation of notch1. J Huazhong Univ Sci Technol [Med Sci], 2012,32(3):370-374
-
(2012)
J Huazhong Univ Sci Technol [Med Sci]
, vol.32
, Issue.3
, pp. 370-374
-
-
Yu, X.1
Zhang, W.D.2
Ning, Q.3
-
6
-
-
84859712831
-
Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients
-
1:CAS:528:DC%2BC38Xks1eqsrc%3D 22136423 10.1111/j.1349-7006.2011.02175.x
-
Mukasa A, Takayanagi S, Saito K, et al. Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients. Cancer Sci, 2012,103(3):587-592
-
(2012)
Cancer Sci
, vol.103
, Issue.3
, pp. 587-592
-
-
Mukasa, A.1
Takayanagi, S.2
Saito, K.3
-
7
-
-
84861101004
-
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway
-
1:CAS:528:DC%2BC3MXhtlOnsrzM 3207317 22059152 10.1158/2159-8290.CD-11- 0102
-
Guo D, Reinitz F, Youssef M, et al. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov, 2011,1(5):442-456
-
(2011)
Cancer Discov
, vol.1
, Issue.5
, pp. 442-456
-
-
Guo, D.1
Reinitz, F.2
Youssef, M.3
-
8
-
-
80052057810
-
Tumorigenesis: The origins of glioma
-
1:CAS:528:DC%2BC3MXhtVKitrfP 21863049 10.1038/nrc3129
-
Alderton GK. Tumorigenesis: the origins of glioma. Nat Rev Cancer, 2011,11(9):627
-
(2011)
Nat Rev Cancer
, vol.11
, Issue.9
, pp. 627
-
-
Alderton, G.K.1
-
9
-
-
34548764357
-
Mucin 15 is expressed in human placenta and suppresses invasion of trophoblast-like cells in vitro
-
1:CAS:528:DC%2BD2sXhtlekt77P 17720698 10.1093/humrep/dem249
-
Shyu MK, Lin MC, Shih JC, et al. Mucin 15 is expressed in human placenta and suppresses invasion of trophoblast-like cells in vitro. Hum Reprod, 2007,22(10):2723-2732
-
(2007)
Hum Reprod
, vol.22
, Issue.10
, pp. 2723-2732
-
-
Shyu, M.K.1
Lin, M.C.2
Shih, J.C.3
-
10
-
-
1242337458
-
Mucins and mucin binding proteins in colorectal cancer
-
1:CAS:528:DC%2BD3sXnsFansrk%3D 15000151 10.1023/A:1025815113599
-
Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer metastasis Rev, 2004,23(1-2):77-99
-
(2004)
Cancer Metastasis Rev
, vol.23
, Issue.1-2
, pp. 77-99
-
-
Byrd, J.C.1
Bresalier, R.S.2
-
11
-
-
79959843718
-
Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma
-
1:CAS:528:DC%2BC3MXotVOksbo%3D 21615302 10.1089/thy.2010.0339
-
Nam KH, Noh TW, Chung SH, et al. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma. Thyroid, 2011,21(7):745-750
-
(2011)
Thyroid
, vol.21
, Issue.7
, pp. 745-750
-
-
Nam, K.H.1
Noh, T.W.2
Chung, S.H.3
-
12
-
-
49649103221
-
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
-
2408576 18442402 10.1186/1755-8794-1-13
-
Riker AI, Enkemann SA, Fodstad O, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Medical Genomics, 2008,1:13
-
(2008)
BMC Medical Genomics
, vol.1
, pp. 13
-
-
Riker, A.I.1
Enkemann, S.A.2
Fodstad, O.3
-
13
-
-
34548386132
-
Mucin gene expression in human middle ear epithelium
-
17667140 10.1097/MLG.0b013e31806db531
-
Kerschner JE. Mucin gene expression in human middle ear epithelium. Laryngoscope, 2007,117(9):1666-1676
-
(2007)
Laryngoscope
, vol.117
, Issue.9
, pp. 1666-1676
-
-
Kerschner, J.E.1
-
14
-
-
79952355186
-
Genome wide analysis of the bovine mucin genes and their gastrointestinal transcription profile
-
1:CAS:528:DC%2BC3MXjslKltbo%3D 3056801 21385362 10.1186/1471-2164-12-140
-
Hoorens PR, Rinaldi M, Li RW, et al. Genome wide analysis of the bovine mucin genes and their gastrointestinal transcription profile. BMC Genomics, 2011,12:140
-
(2011)
BMC Genomics
, vol.12
, pp. 140
-
-
Hoorens, P.R.1
Rinaldi, M.2
Li, R.W.3
-
15
-
-
84890825478
-
Emerging role of mucins for epithelial to mesenchymal transition
-
1:CAS:528:DC%2BC2cXitlWlsg%3D%3D 3924542 24168188 10.2174/ 15680096113136660100
-
Ponnusamy MP, Seshacharyulu P, Lakshmanan I, et al. Emerging role of mucins for epithelial to mesenchymal transition. Curr Cancer Drug Targets, 2013,13(9):945-56
-
(2013)
Curr Cancer Drug Targets
, vol.13
, Issue.9
, pp. 945-956
-
-
Ponnusamy, M.P.1
Seshacharyulu, P.2
Lakshmanan, I.3
-
16
-
-
84880279165
-
Tumour immunomodulation: Mucins in resistance to initiation and maturation of immune response against tumours
-
1:CAS:528:DC%2BC3sXhtFWkt7rM 23298229 10.1111/sji.12019
-
Anandkumar A, Devaraj H. Tumour immunomodulation: mucins in resistance to initiation and maturation of immune response against tumours. Scand J Immunol, 2013,78(1):1-7
-
(2013)
Scand J Immunol
, vol.78
, Issue.1
, pp. 1-7
-
-
Anandkumar, A.1
Devaraj, H.2
-
17
-
-
84867257010
-
Tumor defense systems using O-glycans
-
1:CAS:528:DC%2BC38XhvVGnurbI 23037152 10.1248/bpb.b12-00367
-
Tsuboi S. Tumor defense systems using O-glycans. Biol Pharm Bull, 2012,35(10):1633-1636
-
(2012)
Biol Pharm Bull
, vol.35
, Issue.10
, pp. 1633-1636
-
-
Tsuboi, S.1
-
18
-
-
69449092545
-
Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells
-
1:CAS:528:DC%2BD1MXpsVaktLw%3D 19520792 10.1093/carcin/bgp137
-
Huang J, Che MI, Huang YT, et al. Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells. Carcinogenesis, 2009,30(8):1452-1458
-
(2009)
Carcinogenesis
, vol.30
, Issue.8
, pp. 1452-1458
-
-
Huang, J.1
Che, M.I.2
Huang, Y.T.3
-
19
-
-
84855919389
-
The new TNM classification of tumors of the esophagogastric junction. Surgical consequences
-
1:STN:280:DC%2BC387ktl2rtg%3D%3D 10.1007/s00104-011-2146-0
-
Schuhmacher C, Novotny A, Feith M, et al. The new TNM classification of tumors of the esophagogastric junction. Surgical consequences. Chirurg (German), 2012,83(1):23-30
-
(2012)
Chirurg (German)
, vol.83
, Issue.1
, pp. 23-30
-
-
Schuhmacher, C.1
Novotny, A.2
Feith, M.3
-
20
-
-
84888268472
-
MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients
-
1:CAS:528:DC%2BC3sXhvValurvO 23933603 10.1053/j.gastro.2013.08.009
-
Wang RY, Chen L, Chen HY, et al. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. Gastroenterology, 2013,145(6):1436-1448
-
(2013)
Gastroenterology
, vol.145
, Issue.6
, pp. 1436-1448
-
-
Wang, R.Y.1
Chen, L.2
Chen, H.Y.3
-
21
-
-
80054686286
-
Tumor metastasis: Molecular insights and evolving paradigms
-
1:CAS:528:DC%2BC3MXhtlaksb3N 3261217 22000009 10.1016/j.cell.2011.09.024
-
Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell, 2011,147(2):275-292
-
(2011)
Cell
, vol.147
, Issue.2
, pp. 275-292
-
-
Valastyan, S.1
Weinberg, R.A.2
|